Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MediGene has announced that the European Commission, based on the recommendation by the European regulatory authority EMEA, has granted marketing authorization for the Oracea(r) drug for the treatment of rosacea.
Subscribe to our email newsletter
The regulatory authorities in the individual countries are to implement this decision within 30 days by granting domestic approvals.
The first domestic approvals for Oracea(r) will be granted in Germany, the UK, Italy, Austria, Ireland, Sweden, Finland, Luxembourg, and the Netherlands.